Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus: pathogenesis, viral intermediates, and viral replication.

Jia-Yee Lee1, Stephen Locarnini

  • 1Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn Street, North Melbourne, Victoria 3051, Australia.

Clinics in Liver Disease
|October 16, 2004
PubMed
Summary

Chronic hepatitis B virus (HBV) infection generates diverse viral quasispecies. Suppressing HBV replication is key to preventing drug resistance and managing infection, potentially through combination therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Preventing early childhood transmission of hepatitis B in remote Aboriginal communities in northern Australia.

International journal for equity in health·2023
Same author

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector.

Viruses·2023
Same author

Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern Australia.

International journal for equity in health·2022
Same author

Preface: Special Collection Commemorating John C. Martin.

Antiviral therapy·2022
Same author

Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB.

Journal of hepatology·2022
Same author

Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection.

Journal of viral hepatitis·2022

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Chronic hepatitis B virus (HBV) infection leads to a vast array of viral quasispecies.
  • The compact HBV genome organization and gene overlap impose constraints, impacting quasispecies viability and viral phenotype.
  • Understanding genotype-phenotype relationships is crucial for effective antiviral strategies.

Purpose of the Study:

  • To explore the implications of HBV genome organization on viral quasispecies diversity and viability.
  • To investigate the relationship between viral replication, quasispecies diversity, and drug resistance development.
  • To propose strategies for improved management and potential cure of chronic hepatitis B.

Main Methods:

  • Analysis of HBV genome organization and its impact on viral quasispecies.

Related Experiment Videos

  • Review of factors influencing viral resistance, including selection pressure and replication.
  • Conceptual framework for combination antiviral therapies and viral clearance.

    • Main Results:

    • The compact HBV genome limits the viability of most generated quasispecies.
    • Single mutations can have pleiotropic effects due to gene overlap.
    • Potent inhibition of HBV replication is essential to prevent drug resistance.

    Conclusions:

    • Understanding HBV genome constraints and genotype-phenotype links can refine antiviral treatments.
    • Suppression of viral replication is critical for preventing drug resistance, analogous to HAART for HIV.
    • Achieving a total cure for hepatitis B may necessitate eliminating the intranuclear viral DNA pool through various mechanisms.